Evidence map›Paper›PMID 35886978›Full record

ArticleInternational journal of molecular sciences2022

Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton's Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker.

Paulina Gil-Kulik, Małgorzata Świstowska, Arkadiusz Krzyżanowski, Alicja Petniak, Anna Kwaśniewska, Bartosz J Płachno, Dariusz Galkowski, Anna Bogucka-Kocka, Janusz Kocki

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Influence of Umbilical Cord Blood Biochemical Parameters and Disease Condition on the Expression of the TSG-6 Gene in Umbilical Mesenchymal Stem Cells.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Paulina Gil-KulikDepartment of Clinical Genetics, Medical University of Lublin, 11 Radziwillowska Str., 20-080 Lublin, Poland.ORCID 0000-0003-3119-981X
Małgorzata ŚwistowskaDepartment of Clinical Genetics, Medical University of Lublin, 11 Radziwillowska Str., 20-080 Lublin, Poland.ORCID 0000-0001-9366-3556
Arkadiusz KrzyżanowskiDepartment of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 11 Staszica Str., 20-081 Lublin, Poland.ORCID 0000-0003-1147-3359
Alicja PetniakDepartment of Clinical Genetics, Medical University of Lublin, 11 Radziwillowska Str., 20-080 Lublin, Poland.ORCID 0000-0001-9926-0870
Anna KwaśniewskaDepartment of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 11 Staszica Str., 20-081 Lublin, Poland.ORCID 0000-0003-2553-8635
Bartosz J PłachnoDepartment of Plant Cytology and Embryology, Institute of Botany, Faculty of Biology, Jagiellonian University in Kraków, 9 Gronostajowa St., 30-387 Cracow, Poland.ORCID 0000-0001-5579-5101
Dariusz GalkowskiPathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
Anna Bogucka-KockaChair and Department of Biology and Genetics, Medical University of Lublin, 4a Chodźki St., 20-093 Lublin, Poland.ORCID 0000-0001-8473-7429
Janusz KockiDepartment of Clinical Genetics, Medical University of Lublin, 11 Radziwillowska Str., 20-080 Lublin, Poland.ORCID 0000-0002-9541-6353
Medical University of Lublin · PLJagiellonian University · PLJohnson University · US

Funding

National Centre for Research and Development STRATEGMED III (STRATEGMED3/303570/7/NCBR/2017)Operational Program Development of Eastern Poland 2007-2013, Priority Axis I Modern Economy, Operations I.3 Innovation Promotion "The equipment of innovative laboratories doing research on new medicines used in the therapy of civilization and neoplastic diseases"
6 · The paper itself

Abstract

SOX2 is a recognized pluripotent transcription factor involved in stem cell homeostasis, self-renewal and reprogramming. It belongs to, one of the SRY-related HMG-box (SOX) family of transcription factors, taking part in the regulation of embryonic development and determination of cell fate. Among other functions, SOX2 promotes proliferation, survival, invasion, metastasis, cancer stemness, and drug resistance. SOX2 interacts with other transcription factors in multiple signaling pathways to control growth and survival. The aim of the study was to determine the effect of a parturient's age, umbilical cord blood pH and length of pregnancy on the quality of stem cells derived from Wharton's jelly (WJSC) by looking at birth weight and using

Indexed as

Mesenchymal Stem CellsSOXB1 Transcription FactorsWharton JellyBiomarkersBirth WeightCell DifferentiationFemaleGene ExpressionHumansInfant, NewbornPregnancyTranscription FactorsBiomarkersSOX2 protein, humanSOXB1 Transcription FactorsTranscription Factorsgene expressionmesenchymal stem cellsSOX2WJSC

Identifiers

PMID35886978
PMCPMC9317592
OpenAlexW4285005773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.